Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Klaus A. Hamacher"'
Autor:
Charles W. Stearns, John L. Humm, Luc Bidaut, Howard Amols, Assen S. Kirov, A. Ganin, Sadek Nehmeh, Yusuf E. Erdi, David Leo McDaniel, Klaus A. Hamacher, C. Ross Schmidtlein
Publikováno v:
Medical Physics. 33:198-208
The recently developed GATE (GEANT4 application for tomographic emission) Monte Carlo package, designed to simulate positron emission tomography (PET) and single photon emission computed tomography (SPECT) scanners, provides the ability to model and
Autor:
Shankar Vallabhajosula, Shota Konishi, Paresh J. Kothari, Stanley J. Goldsmith, Neil H. Bander, Diago Bastidas, Klaus A. Hamacher
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 19:706-715
Determination of the immunoreactive fraction (IF) of radiolabeled monoclonal antibodies (MAb) is essential to the understanding of the effects of radiolabeling and subsequent target-specific tumor localization. There has been generally no accepted me
Autor:
Åse Ballangrud, Michael R. McDevitt, George Sgouros, Klaus A. Hamacher, Ronald D. Finn, Dangshe Ma, Joseph G. Jurcic, David A. Scheinberg, Roger Molinet, Steven M. Larson, John Humm, Chaitanya R. Divgi, Martin W. Brechbiel
Publikováno v:
Blood. 100:1233-1239
Unlike β particle–emitting isotopes, α emitters can selectively kill individual cancer cells with a single atomic decay. HuM195, a humanized anti-CD33 monoclonal antibody, specifically targets myeloid leukemia cells and has activity against minim
Autor:
Klaus A. Hamacher, George Sgouros
Publikováno v:
Medical Physics. 28:1857-1874
The toxicity and clinical utility of long-lived alpha emitters such as Ac-225 and Ra-223 will depend upon the fate of alpha-particle emitting unstable intermediates generated after decay of the conjugated parent. For example, decay of Ac-225 to a sta
Autor:
George Sgouros, Klaus A. Hamacher
Publikováno v:
Medical Physics. 26:2526-2528
The dosimetry of alpha particle emitters requires that all decays, including those of unstable intermediates be included in the calculation. Such calculations are complicated by the potential differential biologic distribution of each of the intermed
Autor:
Joseph T. Giacino, Nicholas D. Schiff, Douglas Ballon, Bradley J. Beattie, Richard Watts, Erik J. Kobylarz, Aziz M. Uluç, Henning U. Voss, Linda Heier, Klaus A. Hamacher, Bruce D. McCandliss, Stanley J. Goldsmith, Shankar Vallabhajosula, Jonathan P. Dyke
We used diffusion tensor imaging (DTI) to study 2 patients with traumatic brain injury. The first patient recovered reliable expressive language after 19 years in a minimally conscious state (MCS); the second had remained in MCS for 6 years. Comparis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60d28e25096bba9e25bd2597a2bfc226
https://europepmc.org/articles/PMC1483160/
https://europepmc.org/articles/PMC1483160/
Autor:
Shankar, Vallabhajosula, Stanley J, Goldsmith, Klaus A, Hamacher, Lale, Kostakoglu, Shota, Konishi, Mathew I, Milowski, David M, Nanus, Neil H, Bander
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 46(5)
In radioimmunotherapy, myelotoxicity due to bone marrow radiation-absorbed dose is the predominant factor and frequently is the dose-limiting factor that determines the maximum tolerated dose (MTD). With (90)Y- and (131)I-labeled monoclonal antibodie
Autor:
Shankar, Vallabhajosula, Ichei, Kuji, Klaus A, Hamacher, Shota, Konishi, Lale, Kostakoglu, Paresh A, Kothari, Mathew I, Milowski, David M, Nanus, Neil H, Bander, Stanley J, Goldsmith
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 46(4)
111In-Labeled antibodies and peptides have been routinely used as chemical and biologic surrogates for 90Y-labeled therapeutic agents. However, recent studies have shown that there are significant differences in biodistribution between 111In- and 90Y
Autor:
Joseph G, Jurcic, Steven M, Larson, George, Sgouros, Michael R, McDevitt, Ronald D, Finn, Chaitanya R, Divgi, Ase M, Ballangrud, Klaus A, Hamacher, Dangshe, Ma, John L, Humm, Martin W, Brechbiel, Roger, Molinet, David A, Scheinberg
Publikováno v:
Blood. 100(4)
Unlike beta particle-emitting isotopes, alpha emitters can selectively kill individual cancer cells with a single atomic decay. HuM195, a humanized anti-CD33 monoclonal antibody, specifically targets myeloid leukemia cells and has activity against mi
Autor:
Howard Amols, Klaus A. Hamacher, Yusuf E. Erdi, Assen S. Kirov, Luc Bidaut, John L. Humm, Charles Schmidtlein, Sadek Nehmeh
Publikováno v:
Medical Physics. 32:1900-1901
Purpose: The needs of radiation therapytreatment planning impose higher demands on PET/CT imaging accuracy. The recently developed GATE (Geant4 Application for Tomographic Emission) Monte Carlo package, provides the possibility to model accurately th